| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Medical Officer | Common Stock | 66,849 | $15,242 | $0.2280 | 01 Jan 2025 | Direct |
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Medical Officer | Common Stock | 10,666 | $2,432 | $0.2280 | 01 Jan 2025 | By the Reporting Person's Roth IRA |
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Medical Officer | Common Stock | 2,000 | $456 | $0.2280 | 01 Jan 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 01 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 07 Jan 2025, 16:11 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 19 Jul 2024 | 1 | -$22,069 | 4 | Chief Medical Officer | 24 Jul 2024, 16:05 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 17 Apr 2024 | 0 | $0 | 3/A | Chief Medical Officer | 07 Jan 2025, 16:10 |